1. Home
  2. ENGN vs ABEO Comparison

ENGN vs ABEO Comparison

Compare ENGN & ABEO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • ENGN
  • ABEO
  • Stock Information
  • Founded
  • ENGN 1999
  • ABEO N/A
  • Country
  • ENGN Canada
  • ABEO United States
  • Employees
  • ENGN N/A
  • ABEO N/A
  • Industry
  • ENGN
  • ABEO Biotechnology: Pharmaceutical Preparations
  • Sector
  • ENGN
  • ABEO Health Care
  • Exchange
  • ENGN Nasdaq
  • ABEO Nasdaq
  • Market Cap
  • ENGN 293.1M
  • ABEO 277.6M
  • IPO Year
  • ENGN N/A
  • ABEO 1980
  • Fundamental
  • Price
  • ENGN $7.90
  • ABEO $6.40
  • Analyst Decision
  • ENGN Strong Buy
  • ABEO Strong Buy
  • Analyst Count
  • ENGN 6
  • ABEO 3
  • Target Price
  • ENGN $33.67
  • ABEO $18.00
  • AVG Volume (30 Days)
  • ENGN 135.1K
  • ABEO 206.7K
  • Earning Date
  • ENGN 09-10-2024
  • ABEO 11-15-2024
  • Dividend Yield
  • ENGN N/A
  • ABEO N/A
  • EPS Growth
  • ENGN N/A
  • ABEO N/A
  • EPS
  • ENGN N/A
  • ABEO N/A
  • Revenue
  • ENGN N/A
  • ABEO N/A
  • Revenue This Year
  • ENGN N/A
  • ABEO N/A
  • Revenue Next Year
  • ENGN N/A
  • ABEO $7,097.06
  • P/E Ratio
  • ENGN N/A
  • ABEO N/A
  • Revenue Growth
  • ENGN N/A
  • ABEO 147.52
  • 52 Week Low
  • ENGN $4.42
  • ABEO $3.05
  • 52 Week High
  • ENGN $18.40
  • ABEO $9.01
  • Technical
  • Relative Strength Index (RSI)
  • ENGN 45.34
  • ABEO 52.99
  • Support Level
  • ENGN $8.50
  • ABEO $5.95
  • Resistance Level
  • ENGN $9.06
  • ABEO $6.48
  • Average True Range (ATR)
  • ENGN 0.69
  • ABEO 0.30
  • MACD
  • ENGN -0.16
  • ABEO -0.04
  • Stochastic Oscillator
  • ENGN 3.57
  • ABEO 54.22

About ENGN enGene Holdings Inc.

enGene Holdings Inc is a clinical-stage biotechnology company focused on developing gene therapies to improve the lives of patients. The Company is developing non-viral gene therapies based on its novel and proprietary dually derived chitosan, or DDX, gene delivery platform, which allows localized delivery of multiple gene cargos directly to mucosal tissues and other organs.

About ABEO Abeona Therapeutics Inc.

Abeona Therapeutics Inc is a clinical-stage biopharmaceutical company. The firm is focused on developing gene therapies and plasma-based products for life-threatening rare genetic diseases. Its clinical programs consist of pz-cel, an autologous, engineered cell therapy currently in development for recessive dystrophic epidermolysis bullosa (RDEB). The Company's development portfolio also features adeno-associated virus (AAV)-based gene therapies designed to treat unmet, medically needed ophthalmic diseases using the novel AIM.

Share on Social Networks: